ESR1 and breast cancer: In the present study, we found that ABGE could inhibit the proliferation, invasion, and metastasis of ER+ breast cancer cells MCF-7 and MDA-MB-361, promote apoptosis and inhibit the epithelial-mesenchymal transition (EMT).